noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

California Department of Water[...]

Lake Oroville Update March 20 2026
GeorgiaTech - Georgia Institute of[...]

ATDC Startups Secure Rare FDA ‘Breakthrough Device’ Status
Association of California Water[...]

ACWA Board Adopts Vision Policy Document; Rollout Coming Soon

Healthcare

Iovance Biotherapeutics Inc.

03/20/2026 | Press release | Distributed by Public on 03/20/2026 15:01

Management Change/Compensation (Form 8-K)

Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 17, 2026, Wendy Yarno, a member of the Board of Directors (the "Board") of Iovance Biotherapeutics, Inc. (the "Company"), provided notice to the Board that she will retire from the Board and not be standing for re-election at the Company's annual meeting of stockholders (the "Annual Meeting") currently anticipated to be held in June 2026. Ms. Yarno will serve out her current term as a director of the Company until the Annual Meeting. The decision to retire and not stand for re-election is not due to a disagreement between the Company and Ms. Yarno on any matter regarding the Company's operations, policies, or practices. The Company thanks Ms. Yarno for her service to the Board.

Iovance Biotherapeutics Inc. published this content on March 20, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on March 20, 2026 at 21:01 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]